Newer routes for the production of oseltamivir without the use of shikimic or quinic acids have appeared, but have not been fully commercialized yet. For example, a novel synthesis route has been ...

Neuraminidase inhibitors such as oseltamivir and zanamivir interfere ... which has a key role in the biosynthesis of GTP and viral RNA synthesis — and is active against both human and avian ...

Neuraminidase inhibitors (oseltamivir and zanamivir) are recommended for treatment of severe illness caused by the 2009 pandemic influenza A (H1N1) virus, and their use has also been advocated for ...

Influenza A (H5N1) virus with an amino acid substitution in neuraminidase conferring high-level resistance to oseltamivir was isolated from two of eight Vietnamese patients during oseltamivir ...

September 29, 2009 — The US Food and Drug Administration (FDA) has approved guidelines for emergency use of oseltamivir phosphate 12-mg/mL oral suspension (Tamiflu, Hoffmann-LaRoche Inc ...

Oseltamivir may reduce recovery time for primary care patients with influenza-like illness, especially for older, sicker patients with comorbidities. Despite guideline recommendations, primary ...

The 2017–2018 flu season is seeing record numbers of cases, hospitalizations, and pediatric deaths. Oseltamivir phosphate (usually shortened to oseltamivir), a prescription drug used to prevent and ...

For more information, see the review decision. This guidance replaces NICE technology appraisal guidance on the clinical effectiveness and cost effectiveness of amantadine and oseltamivir for the ...